Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging

被引:1
|
作者
Han, Xue [1 ]
Yang, Huajing [1 ]
Jin, Shiyang [2 ]
Sun, Yunfeng [3 ]
Zhang, Hongxia [3 ]
Shan, Ming [2 ]
Cheng, Wen [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Ultrasound, 150 Japing Rd, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Breast Surg, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Canc Hosp, Imaging Ctr, Harbin, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 02期
关键词
contrast-enhanced; dynamic contrast-enhanced MRI; neoadjuvant chemotherapy; ultrasound; ultrasound breast cancer; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; THERAPY; RECOMMENDATIONS; PRESSURE; OUTCOMES; LESIONS; MRI;
D O I
10.1002/cam4.5019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to evaluate the value of dynamic contrast-enhanced ultrasound (CEUS) combined with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting pathological complete response (pCR) in patients with breast cancer receiving neoadjuvant chemotherapy (NAC). Fifty-seven female patients with breast cancer (mean age, 50.46 years; range, 32-66 years) scheduled for NAC were recruited. CEUS and DCE-MRI were performed before and after NAC. Imaging features and their changes were compared with postoperative pathological results. After the clinical differences were balanced using propensity score matching, univariate and multiple logistic regression analyses were used to derive the characteristics independently associated with pCR. Receiver operating characteristic curve analysis was performed to assess diagnostic performance. After six to eight cycles of NAC, 24 (42.1%) patients achieved pCR, while 33 (57.9%) did not. Multivariate analysis showed that enhancement order on CEUS and DCE-MRI before NAC, reduction in diameter and enhancement shape on CEUS, maximum diameter on DCE-MRI, and the type of progressive dynamic contrast enhancement after NAC were independently associated with pCR after NAC. The area under the receiver operating characteristic curve for CEUS+DCE-MRI was 0.911 (95% confidence interval, 0.826-0.997), and the specificity and positive predictive values were 87.0% and 87.5%. CEUS and DCE-MRI have the potential for assessing the pathological response to NAC in patients with breast cancer; their combination showed the best diagnostic performance. CEUS+DCE-MRI has proved beneficial for comprehensive assessment and personalizing treatment strategies for patients with breast cancer.
引用
收藏
页码:1389 / 1398
页数:10
相关论文
共 50 条
  • [31] Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
    Rix, Anne
    Piepenbrock, Marion
    Flege, Barbara
    von Stillfried, Saskia
    Koczera, Patrick
    Opacic, Tatjana
    Simons, Nina
    Boor, Peter
    Thoroe-Boveleth, Sven
    Deckers, Roel
    May, Jan-Niklas
    Lammers, Twan
    Schmitz, Georg
    Stickeler, Elmar
    Kiessling, Fabian
    THERANOSTICS, 2021, 11 (19): : 9557 - 9570
  • [32] Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging
    Frankhouser, David E.
    Dietze, Eric
    Mahabal, Ashish
    Seewaldt, Victoria L.
    FRONTIERS IN RADIOLOGY, 2021, 1
  • [33] Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging
    Xu, H. D.
    Zhang, Y. Q.
    NEOPLASMA, 2017, 64 (03) : 430 - 436
  • [34] Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
    Yan, Yuling
    Sun, Xilin
    Shen, Baozhong
    ONCOTARGET, 2017, 8 (26) : 43491 - 43505
  • [35] Early Response Detected by Shutter-speed Dynamic Contrast-enhanced Magnetic Resonance Imaging Predicts Complete Pathologic Response of Breast Cancer to Neoadjuvant Chemotherapy
    Hessman, C. J.
    Tudorica, L.
    Oh, K.
    Roy, N.
    Troxell, M.
    Chui, S.
    Huang, W.
    Naik, A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S68 - S68
  • [36] Contrast-enhanced ultrasound for the preoperative prediction of pathological characteristics in breast cancer
    Li, Ling-Ling
    Su, Quan-Li
    Deng, Yun-Xia
    Guo, Wen-Wen
    Lun, Hai-Mei
    Hu, Qiao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] Evaluation of Uterine Fibroid Vascularity Using Contrast-Enhanced Ultrasound in Comparison with Contrast-Enhanced Magnetic Resonance Imaging
    Machado, Priscilla
    Tan, Allison
    Forsberg, Flemming
    Gonsalves, Carin F.
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2024, 50 (03): : 394 - 398
  • [38] The value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in the prediction of neoadjuvant chemotherapy response in breast cancer: A Meta-Analysis
    Dakhil, H. Abed
    Arian, A.
    Ahmadinejad, N.
    Bustan, R. A.
    Sahib, M. A.
    Anjomrooz, M.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (03):
  • [39] Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
    Choi, Eun Jung
    Choi, HyeMi
    Choi, Sin Ae
    Youk, Ji Hyun
    MEDICINE, 2016, 95 (48) : e5330
  • [40] Intestinal perfusion measurements with contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging enterography: A comparison study
    Wilkens, R.
    Peters, D. A.
    Nielsen, A. H.
    Hovgaard, V. P.
    Glerup, H.
    Krogh, K.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S164 - S165